HTHülya Ertaşoğlu Toydemir

Hülya Ertaşoğlu Toydemir

*This is an algorithmically generated author record based on publicly available information.

Hülya Ertaşoğlu Toydemir has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hyperandrogenism and polycystic ovary syndrome phenotypes in idiopathic intracranial hypertension

    by Didem Savaşcı, Hülya Ertaşoğlu Toydemir, Murat Ekin, Vildan Ayşe Yayla

    Background Idiopathic intracranial hypertension (IIH) and polycystic ovary syndrome (PCOS) share several clinical features, including obesity and hyperandrogenism. Although previous studies have suggested an association between these conditions, the relationship between IIH and specific PCOS phenotypes remains incompletely characterized. Aims This study aimed to characterize androgen profiles and evaluate the prevalence and phenotypic distribution of PCOS in women with IIH. Methods In this cross-sectional study, 26 women with IIH and 21 age-matched overweight or obese controls were evaluated. PCOS diagnosis and phenotypic classification were determined according to the Rotterdam criteria. Serum androgen concentrations, clinical and biochemical features of hyperandrogenism were assessed, and body fat distribution patterns were also analyzed. Results Women with IIH demonstrated higher androgen concentrations, including free testosterone and dehydroepiandrosterone sulfate (DHEAS), compared with controls. Among women with IIH, free testosterone levels tended to be higher in those with concomitant PCOS (p = 0.09). Although the overall PCOS prevalence did not differ significantly between groups (38.4% vs 25%, p = 0.29), hyperandrogenic PCOS phenotypes (A-C) were observed exclusively in women with IIH, whereas all PCOS cases in the control group were classified as phenotype D. Among women with PCOS, hyperandrogenism and ovulatory dysfunction were significantly more frequent in the IIH group than in the control group (p = 0.006 and p = 0.005, respectively). Conclusions Women with IIH exhibit increased a higher prevalence of hyperandrogenism and a predominance of hyperandrogenic PCOS phenotypes. These findings support the hypothesis that androgen-related mechanisms may contribute to IIH pathophysiology beyond the effects of obesity alone, highlighting a potential endocrine component linking IIH and PCOS.

  • The clinical profile and therapeutic outcome of patients diagnosed with “atypical” optic neuritis

    by Gülden Akdal, Hülya Ertaşoğlu Toydemir, Meltem Söylev Bajin, Pınar Özçelik, Figen Gökçay, Ayşe İlksen Işıkay, Canan Togay Işıkay, Şebnem Bıçakçı, Aylin Yaman, Pembe Keskinoğlu, et al.

    Purpose Our aim was to evaluate the clinical characteristics and prognosis of patients diagnosed with atypical optic neuritis (AON). Methods We performed a retrospective study in patients with AON collected between 1991 and 2024. Clinical features, laboratory findings, and treatment modalities of patients with AON were investigated and the relationship between therapeutic approaches and the visual prognosis of these patients were evaluated. Results Eighty-eight patients with AON were evaluated and 51 patients were included in the study. Patients were divided in two groups (Group 1: full recovery, Group 2: partial and no recovery). Anti-MOG antibodies were positive in 8 patients. Seven patients out of 8 had full recovery whereas 1 patient had partial recovery. Among 7 patients with AQP4-Ab positivity, 4 patients had no recovery, 1 patient had partial recovery and 2 patients had full recovery. MOG-Ab positivity and intravenous methylprednisolone (IVMP) treatment in patients with full recovery were found to be significantly higher than in patients with partial recovery and no recovery (p = 0.011 and p = 0.010 respectively). Patients who were treated with plasma exchange (PE), intravenous immunoglobulin (IVIg) and immunsupressive agents had longer recovery time according to Kaplan -Meier survival curves (p = 0.023, p = 0.039 and p = 0.032). Conclusion MOG-Ab positivity and IVMP treatment are related with better visual outcome. Early diagnosis and treatment of AON are extremely important to rescue vision. Treatment in patients with AON should be started as soon as possible, even if the serological status is not known at the setting of ON.


  • Comparison of clinical features in patients with vestibular migraine and migraine

    by Neşe Çelebisoy, Ayşın Kısabay Ak, Ceyla Ataç, Hüseyin Nezih Özdemir, Figen Gökçay, Gülsüm Saruhan Durmaz, Dilek Top Kartı, Hülya Ertaşoğlu Toydemir, Vildan Yayla, İlKsen Çolpak Işıkay, et al.

    Vestibular migraine (VM) is accepted as the most common cause of spontaneous episodic vertigo. In most patients, vestibular symptoms follow migraine headaches that begin earlier in life. The aim of this multicenter retrospective study was to find out the differences between migraine patients without any vestibular symptoms (MwoV) and VM patients and to delineate the specific clinical features associated with VM. MwoV and VM patients were compared regarding demographic features, migraine headache years, headache attack frequency, intensity, symptoms associated with headache and vertigo attacks, presence of menopause, history of motion sickness and family history of migraine. Four-hundred and forty patients with MwoV and 408 patients with VM were included in the study. Migraine with aura was more frequent in patients with MwoV (p = 0.035). Migraine headache years was longer (p < 0.001) and headache intensity was higher in patients with VM (p = 0.020). Aural fullness/tinnitus was more common in patients with VM (p < 0.001) when all other associated symptoms were more frequent in patients with MwoV (p < 0.001) as well as attack triggers (p < 0.05). Presence of menopause and motion sickness history was reported more frequently by VM patients (p < 0.001). Logistic regression analysis indicated that longstanding history of migraine with severe headache attacks, aural fullness/tinnitus accompanying attacks, presence of menopause, previous motion sickness history were the differentiating clinical features of patients with VM.


  • Vestibular migraine, demographic and clinical features of 415 patients: A multicenter study

    by Neşe Çelebisoy, Ayşın Kısabay Ak, Hüseyin Nezih Özdemir, Figen Gökçay, Gülsüm Saruhan Durmaz, Dilek Top Kartı, Hülya Ertaşoğlu Toydemir, Vildan Yayla, Ayşe İlksen Çolpak Işıkay, İrEm Erkent, et al.


  • Open Access

    Successful Plasma Exchange in a Pregnant Patient with Guillain-Barré Syndrome and Thyrotoxicosis

    by Hülya E. Toydemir, Vildan Yayla, Metin Mercan, Hacı Ali Erdoğan, İbrahim Acır, Mehmet Hurşitoğlu, Meral Mert, Bahar Özdemir, Yasemin Tekdöş Şeker, Deniz Özel Bilgi, et al.

    Ann Indian Acad Neurol, Official Journal of Indian Academy of Neurology


  • THE PROFILE OF GUILLAIN-BARRÉ SYNDROME BEFORE AND DURING COVID-19 PANDEMIC: A 5-YEAR EXPERIENCE

    by Hülya Ertaşoğlu Toydemir, Metin Mercan, Vildan Ayşe Yayla

    Introduction: We aimed to evaluate and compare the clinical and electrophysiological features of post-COVID-19 Guillain-Barre syndrome (GBS) and non-COVID-19 GBS patients over the last five years.Methods: We retrospectively analyzed patients diagnosed with GBS between October 2016 and September 2021. They were divided into five groups according to the flu season and the COVID-19 pandemic. Groups 1-4 were identified as non-COVID-19 groups, whereas Group 5 constituted the post-COVID-19 group. At the sixth month the Hughes functional grading scale score (HFGSS) was noted. Clinical and electrophysiological findings were compared between the groups. Results: Fifty-nine GBS patientswere enrolled in this study. Post-COVID-19 GBS patients had more facial diplegia than non-COVID-19 GBS patients. Except for facial diplegia, post-COVID-19 GBS patients did not differ from non-COVID-19 GBS patients regarding the need for mechanical ventilation, loss of ambulation, type of GBS, response to treatment, and patient outcomes. In 67% of post-COVID-19 GBS patients, HFGSS was <= 2. Acute inflammatory demyelinating polyneuropathy (AIDP) wab the most common subtype in post-COVID-19 GBS patients. The 2018-2019 flu season saw more ambulation loss than other flu seasons. The 2017-2018 influenza season had the highest number of patients (39%).Conclusion: The clinical and electrophysiological features of GBS may differ according to year, infectious etiology, and severity of seasonal viral infections. Post-COVID-19 GBS patients mostly had the AIDP subtype with frequent facial diplegia. The prognosis of post-COVID-19 GBS patients was good. The patients responded well to treatment with intravenous immunoglobulin and plasma exchange.


  • The Profile and Severity of Causal Factors in Symptomatic Epilepsies

    by Hülya Ertaşoğlu Toydemir, Vildan Yayla, Dilek Bozkurt, Filiz Azman, Hayriye Örnek

  • Open Access

    The relationship between interleukin-6 and epileptic seizure

    by Reyyan Ezer, Hülya Ertaşoğlu Toydemi̇r, Fatma Münevver Gökyiğit

    En tr Aim: The aim of this study was to evaluate the relationship between interleukin-6 (IL-6) levels and the type of the seizure, etiology of the seizure and the infection parameters which were fever, leukocyte count and c-reactive protein (CRP) in epileptic patients. Material and Methods: A total of 48 people were included in the study, containing a patient group of 24 and a control group of 24. IL-6, fever, leukocyte and CRP levels were measured and recorded. The patients were categorized according to the type and etiology of the seizures. The relationship between IL-6 levels and infection parameters, type and etiology of seizures were evaluated. Results: IL-6 levels were significantly higher in epileptic patients than that of the control group. There were no correlations between IL-6 levels and fever, leukocyte and CRP. The patients were evaluated according to the seizure type. There was no significant relationship between IL-6 levels of control group and IL-6 levels of patients with partial epileptic seizures (p=0.270). However, there was significant relationship between IL-6 levels of the control group and that of patients with primary generalized, secondary generalized seizures and generalized status epilepticus (p=0.012, p=0.011 and p=0.040, respectively). Epilepsy etiology was not associated with levels of IL-6. Conclusion: High levels of IL-6 after epileptic seizures might be detected independent from infection parameters and epilepsy etiology. IL-6 levels might be higher in patients with primary generalized, secondary generalized seizures and generalized status epilepticus than that of patients with partial seizures. Amaç: Epileptik nöbet geçiren hastalarda interlökin-6 (IL-6) düzeyinin nöbet türü, etiyolojisi ile infeksiyon parametreleri olan ateş, lökosit ve c-reaktif protein (CRP) ile ilişkisinin incelenmesi amaçlandı. Gereç ve Yöntem: Çalışmaya 24 kişiden oluşan hasta grubu ve 24 kişiden oluşan kontrol grubu olmak üzere toplam 48 kişi dahil edildi. Hastaların IL-6, ateş, lökosit ve CRP değerleri ölçülerek kaydedildi. Hastalar nöbet türüne ve etiyolojisine göre sınıflandırıldı. IL-6 düzeylerindeki yüksekliğin, infeksiyon parametreleri, nöbet türü ve etiyolojisiyle olan ilişkisi değerlendirildi. Bulgular: IL-6 düzeyi nöbet hastalarında kontrol grubuna göre yüksek bulundu. Epilepsi hastalarında IL-6 düzeylerindeki yükselmenin ateş, lökosit ve CRP düzeylerindeki yükselme ile arasında korelasyon bulunmadı. Hastalar nöbet türüne göre değerlendirildi. Hasta grubu ve kontrol grubunun IL-6 düzeyleri karşılaştırıldığında kontrol grubu ile parsiyel nöbet geçiren hastalarla arasında anlamlı fark bulunmazken (p=0,270), primer jeneralize, sekonder jeneralize ve jeneralize status ile arasında anlamlı fark belirlendi (sırasıyla p=0,012, p=0,011, p=0,040). Nöbet etiyolojisi ile IL-6 düzeyleri arasında ilişki saptanmadı. Sonuç: Epileptik nöbet geçiren hastalarda IL-6 düzeyi diğer infeksiyöz parametrelerden ve etiyolojiden bağımsız olarak yüksek saptanabilmektedir. IL-6 düzeyi, primer jeneralize, sekonder jeneralize nöbetlerde ve jeneralize statusta, parsiyel nöbetlere göre anlamlı olarak yüksek bulunabilir.